FENOPROFEN CALCIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for fenoprofen calcium and what is the scope of patent protection?
Fenoprofen calcium
is the generic ingredient in two branded drugs marketed by Am Therap, Halsey, Misemer, Par Pharm, Quantum Pharmics, Rising, Warner Chilcott, Watson Labs, Key Therap, Ani Pharms, Dava Pharms Inc, Ivax Sub Teva Pharms, Strides Pharma, Sun Pharm Industries, Usl Pharma, Watson Labs Teva, and Dista, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.There are nine drug master file entries for fenoprofen calcium. Seven suppliers are listed for this compound.
Summary for FENOPROFEN CALCIUM
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 17 |
| NDAs: | 34 |
| Drug Master File Entries: | 9 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 211 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,283 |
| What excipients (inactive ingredients) are in FENOPROFEN CALCIUM? | FENOPROFEN CALCIUM excipients list |
| DailyMed Link: | FENOPROFEN CALCIUM at DailyMed |
Recent Clinical Trials for FENOPROFEN CALCIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
Pharmacology for FENOPROFEN CALCIUM
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for FENOPROFEN CALCIUM
Anatomical Therapeutic Chemical (ATC) Classes for FENOPROFEN CALCIUM
US Patents and Regulatory Information for FENOPROFEN CALCIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quantum Pharmics | FENOPROFEN CALCIUM | fenoprofen calcium | CAPSULE;ORAL | 071738-001 | Aug 17, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072602-001 | Oct 11, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Halsey | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072357-001 | Aug 17, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dava Pharms Inc | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072326-001 | Aug 17, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072274-001 | May 2, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Warner Chilcott | FENOPROFEN CALCIUM | fenoprofen calcium | CAPSULE;ORAL | 072946-001 | Apr 30, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FENOPROFEN CALCIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Key Therap | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Dista | NALFON | fenoprofen calcium | TABLET;ORAL | 017710-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Key Therap | NALFON | fenoprofen calcium | CAPSULE;ORAL | 017604-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
